<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1448210&amp;fmt=gif">
Free Research

Digital Transformation Benchmarking Index for Pharmaceutical Manufacturers

Price: Starting at USD 1,950
Publish Date: 06 Feb 2026
Code: PT-6041
Research Type: Presentation
Pages: 21
Actionable Benefits

Actionable Benefits

  • Understand which pharmaceutical manufacturers are leading the way, both in terms of implementing digital technologies, and more importantly, generating tangible benefits from such investments.
  • Identify which pharmaceutical manufacturers’ digital initiatives are helping them meet the challenges that the industry faces.
  • Identify the solutions that are meeting the industry’s challenges.              
Research Highlights

Research Highlights

  • Matrix grouping of the largest pharmaceutical manufacturers by digital maturity and impact of digital investments.
  • Strategic recommendations about engaging with pharmaceutical manufacturers.
  • A detailed assessment of ways that pharmaceutical manufacturers are approaching the challenges the industry faces.
  • Use cases outlining how leading firms have utilized digital technologies to improve the workforce.
Critical Questions Answered

Critical Questions Answered

  • What types of digital initiatives are having an impact on pharmaceutical manufacturers?
  • Which pharmaceutical manufacturers stand out in terms of digital maturity?
  • What are some of the most impactful use cases that technology suppliers should get behind to help their pharmaceutical customers?
Who Should Read This?

Who Should Read This?

  • Strategists responsible for improving how their organizations engage with pharmaceutical manufacturers.
  • System integrators that need to identify use cases that may be applicable at their pharmaceutical client sites.
  • Marketing leaders looking to target pharmaceutical manufacturers.
  • Digital leaders at pharmaceutical manufacturers looking to obtain insights covering how different digital technologies can support their operations and to compare themselves with peers.

Companies Mentioned

Table of Contents

Executive Summary 

Introduction and Methodology

Benchmarking Index

Digitally Transformed with Digital Technologies Underpinning How the Manufacturer Meets the Industry’s Challenges

GSK
AstraZeneca
Pfizer
Merck

Embedding Digital Technologies, but Digital Transformation Is Less Advanced Than Competitors

AbbVie
Amgen
Johnson & Johnson
Sanofi

Digitally Transformed, but More Scope Exists to Use Digital Technologies to Meet Industry Challenges

Novartis
Novo Nordisk 
Eli Lilly 
Takeda

Behind Competitors with Regard to Both Digital Transformation and Utilizing Digital Technologies to Meet the Industry’s Challenges

Roche 
Bristol Myers Squibb
Gilead Sciences

Companies Mentioned

  • AbbVie Inc.
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • Gilead Sciences
  • GSK
  • Merck
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
  • Takeda